|
|
|
|
|
| |
Current
Issues - Newsletter
August 1998 |
|
| |
|
|
| |
|
|
| |
Sabinsa®
Corporation assigned patent for Citrin®K
|
|
| |
| |
Sabinsa®
Corporation was recently assigned a patent (U.S. Patent
#5,783,603, dated July 21, 1998) for Citrin®K.
The patent titled "Potassium hydroxycitrate for
the suppression of appetite and induction of weight
loss", provides methods of suppressing appetite,
inhibiting cytoplasmic citrate lyase and increasing
fat metabolism in obese subjects, using the potassium
salt of hydroxycitric acid from Garcinia fruit. Citrin®K
is a water soluble product, available in two forms:
a standardized powdered extract and a standardized liquid. |
|
|
|
|
|
| |
Sabins goes ‘SOFT’: Extracts with added convenience
|
|
| |
| |
Sabinsa®
Corporation is set to introduce a range of "soft"
standardized herbal extracts, with a view towards facilitating
the manufacture of finished soft gel dosage forms. The
soft gel is a consumer convenient and highly acceptable
dosage form which can be formulated to mask taste and
odor. Bioavailability and stability of low dose active
ingredients may also be enhanced.In certain functional
food products, powdered extracts could present solubility/dispersibility
problems. A soft extract would be particularly useful
in such cases. Ginger soft extract is currently availiable.
Gugulipid® the standardized
extract of Commiphora mukul, and Ashwagandha (Withania
somnifera) extract will also be available in the near
future.
|
|
|
|
|
|
| |
Rrsearch focus : Dr. S. Natarajan
|
|
| |
| |
 |
Dr. S.
Natarajan is Executive Vice President, Research,
at Sami Chemicals and Extracts Ltd., Bangalore,
India, a company owned by Sabinsa Corporation.
He is also one of the directors of the company.
Dr. Natarajan obtained a doctorate in synthetic
and natural products chemistry from the University
of Madras, India. He subsequently held post doctoral
research positions in leading U.S.universities,
including the University of North Carolina, Duke
University and Stanford University, California.
He also worked with prominent manufacturers in
India, developing a wide range of products. |
Dr. Natarajan joined the SAMI team in 1994, bringing
with him over 20 years of research and development
experience. With his extensive background in organic
chemistry including alkaloids research and synthesis
of chiral compounds, Dr. Natarajan imparts a well-founded
innovative approach to developing new products and
cost effective manufacturing processes, for the
growing list of standardized extracts, fine chemicals
and nutritional raw materials supplied by Sabinsa®
Corporation. |
|
|
|
|
|
|
| |
Visit
us on the web : www.sabinsa.com |
|
| |
| |
The
web pages contain detailed information on Sabinsa’s
products, services and people; information brochures;
technical articles and back issues of the company newsletter.
Do stop by and post your
comments in our guest book. We look forward to your
suggestions, to help us serve you better.
www.sabinsa.com
|
|
|
|
|
|
| |
Sabinsa®
Corporation to participate in Japanese Trade Show |
|
| |
| |
Sabinsa®
Corporation will participate in Health Ingredients Japan
(September 16-18, 1998), which is an integral part of
the International Food Design Show that has been held
anually in Tokyo since 1990. It is the leading exhibition
in Japan for food ingredients, with special emphasis on
health foods, functional foods, nutraceuticals and organic
foods.
A parallel drug store exhibition
at the site offers manufacturers of finished products
direct access to retailers and distributors of health
food products. In addition, conferences and seminars
will be held in conjunction with the show, making this
event the most comprehensive one of its kind in Japan. |
|
|
|
|
|
| |
Procuts
for topical use from Sabinsa Corporation |
|
| |
| |
Sabinsa®
Corporation supplies several ingredients for use in topical
formulations. These include fine chemicals and herbal
extracts. A few are described here:
- Aleuritic acid, a potential substitute
for alpha-hydroxy acids and valued for its antioxidant
action on the skin.
- Boswellin®,
the standardized extract (65% boswellic acids) from
Boswellia serrata is a clinically proven anti-inflammatory
agent.
- Capsaicin, from Capsicum annum is classified
by the FDA as a counterirritant, a substance which
may be deliberately applied to the skin to relieve
more serious symptoms such as inflammation and pain.
Three types of standardized Capsaicin products are
available: 40% capsaicinoids, for topical use only;
75% capsaicinoids, two grades, for topical and oral
use, respectively and 95% capsaicinoids, which conforms
to USP specifications, for topical use.
- Centellin®,
the standardized extract from Centella asiatica contains
triterpenoid saponins (8.0% triterpenes, with a minimum
of 0.5% asiaticoside). Centella asiatica has been
used traditionally in the management of skin disorders.
The extract has also been included in anti-aging creams
and other topical formulations useful in retarding
free radical mediated degenerative changes in the
skin.
- Green tea extract is standardized for
a minimum of 75% catechins. The catechins are proven
antioxidants, useful in retarding the damaging effects
of ultraviolet light and other free radical inducing
factors. This extract could therefore be included
in antiaging and skin protective formulations.
- White curcuminoids, otherwise
known as Tetrahydrocurcuminoids, is a patent pending
derivative of curcuminoids (the antioxidant principles
in Curcuma longa). This color free product finds increasing
applications in cosmetics.
Ongoing research at Sabinsa Corporation
continues to find other products with potential applications
in cosmetics. |
|
|
| |
|
|
| |
| "The information
presented in the "Current Issues" Newsletter
from Sabinsa Corporation is for informational purposes
only. It is abstracted from web and print media
sources. Readers are advised to refer to the original
sources for additional information". |
|
|
|
| |
|
|
|
